Main page content

Displaying results 21 - 30 of 37
Publication ID: PEP22-08-03-006
Published:

This 18x24 inch poster helps publicize the new 988 Suicide & Crisis Lifeline and provides access to this life-saving resource. This poster is designed to be placed in schools, community centers, counseling offices, clinics, and other settings where people gather.

Publication ID: PEP22-08-03-009
Published:
Este imán con forma de teléfono móvil (tamaño 3,25"x6") ayuda a publicitar el nuevo 988 Línea de Prevención del Suicido y Crisis y proporciona acceso a este recurso que salva vidas en lugares muy visibles.
Publication ID: PEP22-08-03-007
Published:

The Safety Plan is a 5”x7” pad, similar to a prescription pad, with 50 sheets of pull off plans. The intended use is for counselors, therapists, clinicians, and others working with people in need of safety plans. It is modified from Stanley & Brown.

Publication ID: PEP21-06-01-002
Published:

This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.

Publication ID: PEP21-06-05-002
Published:

This guide reviews literature on treating college students’ mental health concerns, such as anxiety, depression, and suicidal thoughts and behaviors; distills the research into recommendations for practice; and provides examples of the ways that these recommendations can be implemented.

Publication ID: PEP21-06-02-002
Published:

This guide intends to educate clinicians and other stakeholders about the harms of using more than one substance and consideration for addressing concurrent substance use (CSU) and concurrent substance use disorders (CSUD).

Publication ID: PEP21-02-01-003
Published:

The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.

Publication ID: PEP21-02-01-002
Published:

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.

Publication ID: PEP20-06-04-002
Published:

This Advisory is based on TIP 51, Substance Abuse Treatment: Addressing the Specific Needs of Women. It offers guidance to providers and administrators about the particular needs of women during substance use disorder (SUD) treatment.

Publication ID: PEP21-PL-Guide-5
Published:

This guide examines emerging and best practices for initiating medication-assisted treatment in emergency departments. It also reviews the existing literature and science of the topic, identifies gaps in knowledge, and discusses challenges of implementation.

Displaying 21 - 30 out of 37